Titre : Banques de tissus

Banques de tissus : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Banques de tissus : Questions médicales les plus fréquentes", "headline": "Banques de tissus : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Banques de tissus : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-22", "dateModified": "2025-04-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Banques de tissus" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Biobanques", "url": "https://questionsmedicales.fr/mesh/D018070", "about": { "@type": "MedicalCondition", "name": "Biobanques", "code": { "@type": "MedicalCode", "code": "D018070", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N02.278.065" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Banques d'os", "alternateName": "Bone Banks", "url": "https://questionsmedicales.fr/mesh/D018586", "about": { "@type": "MedicalCondition", "name": "Banques d'os", "code": { "@type": "MedicalCode", "code": "D018586", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N02.278.065.900.205" } } }, { "@type": "MedicalWebPage", "name": "Banques des yeux", "alternateName": "Eye Banks", "url": "https://questionsmedicales.fr/mesh/D005125", "about": { "@type": "MedicalCondition", "name": "Banques des yeux", "code": { "@type": "MedicalCode", "code": "D005125", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "N02.278.065.900.400" } } } ], "about": { "@type": "MedicalCondition", "name": "Banques de tissus", "alternateName": "Tissue Banks", "code": { "@type": "MedicalCode", "code": "D014015", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Victoria Stadler Tasca Ribeiro", "url": "https://questionsmedicales.fr/author/Victoria%20Stadler%20Tasca%20Ribeiro", "affiliation": { "@type": "Organization", "name": "Division of Infectious Diseases, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil." } }, { "@type": "Person", "name": "Luciana Cristina Wollmann", "url": "https://questionsmedicales.fr/author/Luciana%20Cristina%20Wollmann", "affiliation": { "@type": "Organization", "name": "Human Tissues Bank, Pontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil." } }, { "@type": "Person", "name": "Paula Hansen Suss", "url": "https://questionsmedicales.fr/author/Paula%20Hansen%20Suss", "affiliation": { "@type": "Organization", "name": "Division of Infectious Diseases, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil." } }, { "@type": "Person", "name": "Felipe Francisco Tuon", "url": "https://questionsmedicales.fr/author/Felipe%20Francisco%20Tuon", "affiliation": { "@type": "Organization", "name": "Division of Infectious Diseases, School of Medicine, Pontifícia Universidade Católica do Paraná, Curitiba, PR, Brazil. felipe.tuon@pucpr.br." } }, { "@type": "Person", "name": "Giulia Montagner", "url": "https://questionsmedicales.fr/author/Giulia%20Montagner", "affiliation": { "@type": "Organization", "name": "Fondazione Banca dei Tessuti del Veneto (FBTV), 31100 Treviso, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Comparison of tissue factor-activated versus citrated native thromboelastography in dogs with suspected hemostatic abnormalities.", "datePublished": "2024-09-20", "url": "https://questionsmedicales.fr/article/39301875", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/10406387241280602" } }, { "@type": "ScholarlyArticle", "name": "Ulinastatin attenuated cardiac ischaemia/reperfusion injury by suppressing activation of the tissue kallikrein-kinin system.", "datePublished": "2024-09-18", "url": "https://questionsmedicales.fr/article/39294926", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/bph.16477" } }, { "@type": "ScholarlyArticle", "name": "Proteomic Analysis Reveals Differential Protein Expression in Placental Tissues of Early-Onset Preeclampsia Patients.", "datePublished": "2024-09-17", "url": "https://questionsmedicales.fr/article/39287518", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acs.jproteome.4c00404" } }, { "@type": "ScholarlyArticle", "name": "Raman microspectroscopy and laser-induced breakdown spectroscopy for the analysis of polyethylene microplastics in human soft tissues.", "datePublished": "2024-09-11", "url": "https://questionsmedicales.fr/article/39315169", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.heliyon.2024.e37844" } }, { "@type": "ScholarlyArticle", "name": "Comparative Tissue Identification and Characterization of Long Non-Coding RNAs in the Globally Distributed Blue Shark", "datePublished": "2024-09-11", "url": "https://questionsmedicales.fr/article/39337927", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/life14091144" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Établissements, main d'oeuvre et services de soins de santé", "item": "https://questionsmedicales.fr/mesh/D005159" }, { "@type": "ListItem", "position": 3, "name": "Établissements de santé", "item": "https://questionsmedicales.fr/mesh/D006268" }, { "@type": "ListItem", "position": 4, "name": "Biobanques", "item": "https://questionsmedicales.fr/mesh/D018070" }, { "@type": "ListItem", "position": 5, "name": "Banques de tissus", "item": "https://questionsmedicales.fr/mesh/D014015" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Banques de tissus - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Banques de tissus", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-04-30", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Banques de tissus", "description": "Comment sont diagnostiquées les maladies nécessitant des tissus ?\nQuels tests sont utilisés pour évaluer la qualité des tissus ?\nLes banques de tissus effectuent-elles des diagnostics ?\nQuels critères sont utilisés pour sélectionner les tissus ?\nComment les tissus sont-ils prélevés pour analyse ?", "url": "https://questionsmedicales.fr/mesh/D014015?page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Banques de tissus", "description": "Quels symptômes peuvent indiquer un besoin de greffe de tissu ?\nLes maladies liées aux tissus présentent-elles des symptômes spécifiques ?\nComment les symptômes influencent-ils le choix des tissus ?\nLes symptômes peuvent-ils varier selon le donneur de tissu ?\nQuels symptômes sont associés aux rejets de greffe ?", "url": "https://questionsmedicales.fr/mesh/D014015?page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Banques de tissus", "description": "Comment prévenir les infections lors de greffes ?\nQuelles mesures sont prises pour éviter le rejet ?\nLes banques de tissus effectuent-elles des tests de dépistage ?\nComment sensibiliser le public sur le don de tissus ?\nQuelles sont les recommandations pour les donneurs potentiels ?", "url": "https://questionsmedicales.fr/mesh/D014015?page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Banques de tissus", "description": "Quels traitements utilisent des tissus de banques ?\nComment les tissus sont-ils préparés pour les traitements ?\nLes banques de tissus participent-elles à la recherche ?\nQuels sont les risques associés aux traitements par greffe ?\nLes traitements par tissus sont-ils toujours efficaces ?", "url": "https://questionsmedicales.fr/mesh/D014015?page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Banques de tissus", "description": "Quelles complications peuvent survenir après une greffe ?\nComment gérer les complications post-greffe ?\nLes complications varient-elles selon le type de tissu ?\nQuels signes indiquent une complication après greffe ?\nLes complications peuvent-elles être évitées ?", "url": "https://questionsmedicales.fr/mesh/D014015?page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Banques de tissus", "description": "Quels facteurs augmentent le risque de rejet ?\nLe tabagisme influence-t-il le succès des greffes ?\nComment l'âge affecte-t-il le don de tissus ?\nLes antécédents médicaux influencent-ils le don de tissus ?\nQuels comportements à risque affectent le don de tissus ?", "url": "https://questionsmedicales.fr/mesh/D014015?page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment sont diagnostiquées les maladies nécessitant des tissus ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les maladies sont diagnostiquées par des examens cliniques, imageries et analyses de tissus." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la qualité des tissus ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests histologiques et microbiologiques sont effectués pour évaluer la qualité." } }, { "@type": "Question", "name": "Les banques de tissus effectuent-elles des diagnostics ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Non, elles ne diagnostiquent pas, mais fournissent des tissus pour des diagnostics." } }, { "@type": "Question", "name": "Quels critères sont utilisés pour sélectionner les tissus ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les tissus sont sélectionnés selon des critères de qualité, d'origine et d'usage prévu." } }, { "@type": "Question", "name": "Comment les tissus sont-ils prélevés pour analyse ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les tissus sont prélevés par biopsie ou lors de chirurgies, sous conditions stériles." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un besoin de greffe de tissu ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la douleur chronique ou la défaillance d'organe peuvent indiquer ce besoin." } }, { "@type": "Question", "name": "Les maladies liées aux tissus présentent-elles des symptômes spécifiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque maladie peut avoir des symptômes spécifiques selon le type de tissu affecté." } }, { "@type": "Question", "name": "Comment les symptômes influencent-ils le choix des tissus ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes aident à déterminer le type de tissu nécessaire pour le traitement approprié." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils varier selon le donneur de tissu ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'état de santé du donneur et de son historique." } }, { "@type": "Question", "name": "Quels symptômes sont associés aux rejets de greffe ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la douleur, la fièvre et l'inflammation peuvent indiquer un rejet." } }, { "@type": "Question", "name": "Comment prévenir les infections lors de greffes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Des protocoles stricts de stérilisation et de suivi post-greffe sont essentiels." } }, { "@type": "Question", "name": "Quelles mesures sont prises pour éviter le rejet ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des immunosuppresseurs sont administrés pour réduire le risque de rejet après greffe." } }, { "@type": "Question", "name": "Les banques de tissus effectuent-elles des tests de dépistage ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles effectuent des tests pour dépister les maladies transmissibles chez les donneurs." } }, { "@type": "Question", "name": "Comment sensibiliser le public sur le don de tissus ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes d'information et d'éducation sont menées pour encourager le don de tissus." } }, { "@type": "Question", "name": "Quelles sont les recommandations pour les donneurs potentiels ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les donneurs doivent être en bonne santé et respecter les critères d'éligibilité établis." } }, { "@type": "Question", "name": "Quels traitements utilisent des tissus de banques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les greffes de peau, de cornée et d'organes utilisent des tissus provenant de banques." } }, { "@type": "Question", "name": "Comment les tissus sont-ils préparés pour les traitements ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les tissus sont stérilisés, conservés et parfois modifiés pour s'adapter aux traitements." } }, { "@type": "Question", "name": "Les banques de tissus participent-elles à la recherche ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles fournissent des tissus pour la recherche sur les maladies et les traitements." } }, { "@type": "Question", "name": "Quels sont les risques associés aux traitements par greffe ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent le rejet, les infections et les complications liées à l'anesthésie." } }, { "@type": "Question", "name": "Les traitements par tissus sont-ils toujours efficaces ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité dépend de nombreux facteurs, y compris la compatibilité et l'état du patient." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une greffe ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent le rejet, les infections et des réactions allergiques." } }, { "@type": "Question", "name": "Comment gérer les complications post-greffe ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier et des traitements appropriés sont nécessaires pour gérer les complications." } }, { "@type": "Question", "name": "Les complications varient-elles selon le type de tissu ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent varier selon le type de tissu greffé et l'état du patient." } }, { "@type": "Question", "name": "Quels signes indiquent une complication après greffe ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la douleur accrue, la fièvre ou l'inflammation peuvent indiquer une complication." } }, { "@type": "Question", "name": "Les complications peuvent-elles être évitées ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être évitées par une bonne préparation et un suivi rigoureux." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de rejet ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la compatibilité tissulaire, l'âge et l'état de santé général du patient." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le succès des greffes ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut compromettre la guérison et augmenter le risque de complications." } }, { "@type": "Question", "name": "Comment l'âge affecte-t-il le don de tissus ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "L'âge peut influencer la qualité des tissus et la décision d'accepter un don." } }, { "@type": "Question", "name": "Les antécédents médicaux influencent-ils le don de tissus ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies transmissibles peuvent rendre un donneur inéligible." } }, { "@type": "Question", "name": "Quels comportements à risque affectent le don de tissus ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des comportements comme l'usage de drogues ou des relations sexuelles non protégées peuvent affecter l'éligibilité." } } ] } ] }

Sources (10000 au total)

Ulinastatin attenuated cardiac ischaemia/reperfusion injury by suppressing activation of the tissue kallikrein-kinin system.

Ulinastatin has beneficial effects in patients undergoing coronary artery bypass grafting (CABG) surgery due to its anti-inflammatory properties, but the underlying mechanism remains unclear.... We used samples from patients undergoing CABG, a model of cardiac ischaemia-reperfusion injury (IRI) in mice and murine cardiac endothelial cell cultures to investigate links between ulinastatin, the ... Ulinastatin inhibited the activity of tissue kallikrein, a key enzyme of the KKS, at 24 h after CABG surgery, which was verified in our murine cardiac ischaemia-reperfusion model. Under normal conditi... Treatment with ulinastatin exerts a protective influence on cardiac reperfusion by suppressing activation of the kallikrein-kinin system. Our findings highlight the potential of targeting kallikrein /...

Evaluation of epicardial adipose tissue thickness and carotid intima-media thickness in children with Behçet's disease.

Behçet's disease (BD) is a systemic vasculitis affecting all sizes of arteries and veins. Approximately 5-10% of patients with BD are present during childhood. The chronic nature of the disease may le... This cross-sectional study evaluated 30 patients with juvenile-onset BD and age-sex-matched 20 healthy controls. The CIMT and EAT thickness were measured by the same paediatric cardiologist. The assoc... Thirty children with BD and 20 age-sex-matched healthy volunteers enrolled in the study. The most common BD-related feature was oral aphthous (n=30), followed by mucocutaneous findings (n=22). Uveitis... Increased EAT thickness may be a risk factor for early atherosclerosis in patients with BD. The EAT thickness was found to be significantly higher in paediatric BD patients. Confirmation of results in...

Assessment of the humoral immune status of varicella-zoster virus in patients with diffuse connective tissue diseases.

Diffuse connective tissue diseases (DCTDs) require long-term immunosuppressive treatment, increasing the risk of varicella-zoster virus (VZV) infection. This study aims to evaluate the humoral immune ... This is a retrospective cohort study that collected data from adult DCTD patients (≥18 years) attending our outpatient clinic. The geometric mean concentration (GMC) of VZV-specific IgG antibodies in ... A total of 280 RA patients, 272 SLE + MCTD patients and 280 healthy controls were included. SLE + MCTD patients had significantly higher VZV IgG antibody levels than RA patients (... Although DCTD patients, particularly those with SLE and MCTD, exhibit higher VZV IgG antibody levels, they still face a higher risk of developing herpes zoster (HZ), which may be related to their unde...

Single-cell analysis of peri-implant gingival tissue to assess implant biocompatibility and immune response.

The innate immune response, particularly the reaction of polymorphonuclear neutrophils (PMNs), is crucial in shaping the outcomes of chronic inflammation, fibrosis, or osseointegration following bioma... We performed bioinformatics analysis and established a peri-implant inflammation model by inserting two titanium implants into the maxillary region, to examine the immune response.... Bioinformatics analysis revealed that titanium implants triggered a host immune response, primarily mediated by PMNs. In the in vivo experiments, we observed a rapid PMN-mediated response, with increa... Our findings indicate that persistent attachment of the short-living PMNs to titanium implants can serve as an indicator or traits of peri-implant inflammation. Therefore, analyzing gingival tissue at...